CTVA · Corteva, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.91B | - | $2.62B | $6.46B | $4.42B | - | $2.33B | $6.11B | $4.49B | - |
| Cost of Revenue | $2.37B | - | $1.64B | $2.93B | $2.34B | - | $1.56B | $2.92B | $2.55B | - |
| Gross Profit | $2.53B | - | $974.00M | $3.52B | $2.08B | - | $761.00M | $3.19B | $1.94B | - |
| R&D | $341.00M | - | $351.00M | $375.00M | $335.00M | - | $348.00M | $357.00M | $332.00M | - |
| SG&A | $877.00M | - | $725.00M | $1.16B | $751.00M | - | $671.00M | $1.05B | $736.00M | - |
| Total Operating Expenses | - | - | - | - | - | - | - | - | - | - |
| D&A | $297.00M | - | - | $312.00M | $296.00M | - | - | - | $307.00M | - |
| Operating Income | $858.00M | - | ($370.00M) | $1.80B | $784.00M | - | ($633.00M) | $1.34B | $482.00M | - |
| Interest Expense | - | - | - | - | - | - | - | - | - | - |
| Income Tax | $133.00M | - | ($62.00M) | $422.00M | $117.00M | - | ($114.00M) | $282.00M | $106.00M | - |
| Net Income | $720.00M | - | ($320.00M) | $1.31B | $652.00M | - | ($524.00M) | $1.05B | $419.00M | - |
| EPS - Basic | $1.07 | - | ($0.47) | $1.92 | $0.95 | - | ($0.76) | $1.51 | $0.60 | - |
| EPS - Diluted | $1.07 | - | ($0.47) | $1.92 | $0.95 | - | ($0.76) | $1.51 | $0.60 | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.96B | $4.52B | $2.51B | $2.06B | $2.01B | $3.11B | $2.42B | $1.84B | $1.50B | $2.64B |
| Accounts Receivable | $7.26B | $4.88B | $5.05B | $5.96B | $6.76B | $4.45B | $4.26B | $5.17B | $6.32B | $4.21B |
| Inventory | $5.20B | $5.67B | $5.31B | $4.32B | $5.13B | $5.43B | $5.67B | $4.89B | $6.18B | $6.90B |
| Accounts Payable | $4.19B | $4.40B | $4.34B | $3.83B | $3.90B | $4.04B | $3.75B | $3.30B | $3.61B | $4.28B |
| Current Assets | $17.39B | $17.34B | $16.44B | $16.00B | $16.59B | $15.10B | $15.65B | $15.36B | $17.16B | $16.26B |
| Total Assets | $42.72B | $42.84B | $42.20B | $41.76B | $42.12B | $40.83B | $41.91B | $41.46B | $43.63B | $43.00B |
| Current Liabilities | $11.85B | $12.13B | $10.42B | $9.52B | $11.48B | $10.39B | $10.42B | $8.95B | $11.33B | $10.41B |
| Long-term Debt | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - | - | - | - | - | - |
| Stockholders' Equity | $24.36B | $24.14B | $25.22B | $25.91B | $24.29B | $23.79B | $24.74B | $25.18B | $24.77B | $25.04B |
| Retained Earnings | $436.00M | ($67.00M) | $834.00M | $1.53B | $587.00M | $55.00M | $98.00M | $992.00M | $302.00M | ($41.00M) |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ($2.89B) | - | - | - | ($2.11B) | - | - | - | ($2.61B) | - |
| Investing Cash Flow | ($77.00M) | - | - | - | ($34.00M) | - | - | - | ($270.00M) | - |
| Financing Cash Flow | $389.00M | - | - | - | $995.00M | - | - | - | $1.77B | - |
| CapEx | $81.00M | - | - | - | $94.00M | - | - | - | $148.00M | - |
| Free Cash Flow | ($2.97B) | - | - | - | ($2.20B) | - | - | - | ($2.76B) | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 51.6% | - | 37.2% | 54.6% | 47.0% | - | 32.7% | 52.3% | 43.2% | - |
| Operating margin | 17.5% | - | -14.1% | 27.9% | 17.7% | - | -27.2% | 21.9% | 10.7% | - |
| EBITDA margin | 23.5% | - | - | 32.8% | 24.5% | - | - | - | 17.6% | - |
| Net margin | 14.7% | - | -12.2% | 20.4% | 14.8% | - | -22.5% | 17.2% | 9.3% | - |
| Free cash flow margin | -60.6% | - | - | - | -49.9% | - | - | - | -61.4% | - |
| FCF / Net income | -4.13 | - | - | - | -3.38 | - | - | - | -6.58 | - |
| R&D / Revenue | 7.0% | - | 13.4% | 5.8% | 7.6% | - | 15.0% | 5.8% | 7.4% | - |
| SG&A / Revenue | 17.9% | - | 27.7% | 17.9% | 17.0% | - | 28.8% | 17.2% | 16.4% | - |
| Effective tax rate | 15.6% | - | - | 24.3% | 15.2% | - | - | 21.1% | 20.2% | - |
| Return on assets | 1.7% | - | -0.8% | 3.1% | 1.5% | - | -1.3% | 2.5% | 1.0% | - |
| Return on equity | 3.0% | - | -1.3% | 5.1% | 2.7% | - | -2.1% | 4.2% | 1.7% | - |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 1.47 | 1.43 | 1.58 | 1.68 | 1.44 | 1.45 | 1.50 | 1.72 | 1.51 | 1.56 |
| Quick ratio | 1.03 | 0.96 | 1.07 | 1.23 | 1.00 | 0.93 | 0.96 | 1.17 | 0.97 | 0.90 |
| Cash ratio | 0.17 | 0.37 | 0.24 | 0.22 | 0.17 | 0.30 | 0.23 | 0.21 | 0.13 | 0.25 |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | - | - | - | - | - | - | - | - | - | - |
| Equity multiplier | 1.75 | 1.77 | 1.67 | 1.61 | 1.73 | 1.72 | 1.69 | 1.65 | 1.76 | 1.72 |
| Liabilities / Assets | - | - | - | - | - | - | - | - | - | - |
| Efficiency | ||||||||||
| Asset turnover | 0.11 | - | 0.06 | 0.15 | 0.10 | - | 0.06 | 0.15 | 0.10 | - |
| Inventory turnover | 0.46 | - | 0.31 | 0.68 | 0.46 | - | 0.28 | 0.60 | 0.41 | - |
| Days sales outstanding | 540d | - | 704d | 337d | 559d | - | 668d | 309d | 514d | - |
| Days inventory outstanding | 800d | - | 1179d | 537d | 800d | - | 1323d | 612d | 885d | - |
| Days payable outstanding | 644d | - | 963d | 477d | 609d | - | 875d | 413d | 516d | - |
| Cash conversion cycle | 697d | - | 920d | 398d | 750d | - | 1117d | 508d | 882d | - |
| Valuation | ||||||||||
| P / E | 78.2x | - | - | 38.8x | 66.2x | - | - | 35.7x | 96.1x | - |
| P / B | 2.3x | - | 1.8x | 2.0x | 1.8x | - | 1.6x | 1.5x | 1.6x | - |
| P / S | 11.5x | - | 17.5x | 7.9x | 9.8x | - | 17.5x | 6.2x | 9.0x | - |
| EV / EBITDA | 47.1x | - | - | 23.1x | 38.1x | - | - | - | 49.5x | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 11.0% | - | 12.6% | 5.6% | -1.7% | - | -10.2% | 1.1% | -8.0% | - |
| Revenue CAGR (3y) | 0.1% | - | -1.9% | 1.1% | -1.4% | - | -0.6% | 2.8% | 2.4% | - |
| Revenue CAGR (5y) | 3.3% | - | 7.0% | 4.5% | 2.2% | - | 3.6% | 1.9% | -6.5% | - |
| Gross profit growth (YoY) | 22.1% | - | 28.0% | 10.3% | 6.8% | - | -19.4% | 9.8% | -8.1% | - |
| Operating income growth (YoY) | 9.4% | - | 41.5% | 34.8% | 62.7% | - | -42.6% | - | -37.9% | - |
| Net income growth (YoY) | 10.4% | - | 38.9% | 24.8% | 55.6% | - | -63.2% | 47.5% | -29.6% | - |
| EPS growth (YoY) | 12.6% | - | 38.2% | 27.2% | 58.3% | - | -68.9% | 51.0% | -27.7% | - |
| EPS CAGR (3y) | 8.8% | - | - | 13.0% | 6.8% | - | - | 4.9% | -9.1% | - |
| EPS CAGR (5y) | 6.0% | - | - | 13.7% | 21.4% | - | - | 10.4% | - | - |
| FCF growth (YoY) | -34.9% | - | - | - | 20.1% | - | - | - | 20.4% | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | 0.3% | 1.5% | 1.9% | 2.9% | -1.9% | -5.0% | -1.9% | -4.0% | -3.3% | -1.0% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$17.40B totalSeed$9.90B · 56.9%
Crop Protection$7.50B · 43.1%
Product / service
$16.96B totalCorn$7.00B · 41.3%
Herbicides$3.73B · 22.0%
Soybean$1.88B · 11.1%
Insecticides$1.67B · 9.8%
Fungicides$1.14B · 6.7%
Otheroilseeds$644.00M · 3.8%
Biologicals$519.00M · 3.1%
Other$374.00M · 2.2%
Geographic
$21.82B totalUS$8.27B · 37.9%
North America$6.27B · 28.7%
BR$2.90B · 13.3%
Latin America$1.61B · 7.4%
EMEA$1.56B · 7.1%
CA$755.00M · 3.5%
Asia Pacific$453.00M · 2.1%
Peer comparison
Same SIC group: Agricultural Production-Crops
| Company | Revenue (last FY) | Net margin | ROE |
|---|---|---|---|
| FDP | $4.32B | 2.1% | 4.5% |
| VRNO | $821.50M | -31.4% | -36.6% |
| CBSTF | - | - | - |
| GTII/GTBIF | $1.18B | 9.7% | 6.0% |
| GRAM | - | - | - |
Comparing Corteva against the 5 most active filers in the same SIC group.
Dividends
$0.72/share trailing 12 months · +5.9% YoY
| Ex-date | Per share |
|---|---|
| Jun 1, 2026 | $0.1800 |
| Mar 2, 2026 | $0.1800 |
| Dec 1, 2025 | $0.1800 |
| Sep 2, 2025 | $0.1800 |
| Jun 2, 2025 | $0.1700 |
| Mar 3, 2025 | $0.1700 |
| Dec 2, 2024 | $0.1700 |
| Sep 3, 2024 | $0.1700 |
| Jun 4, 2024 | $0.1600 |
| Feb 29, 2024 | $0.1600 |
| Nov 30, 2023 | $0.1600 |
| Aug 31, 2023 | $0.1600 |
| May 31, 2023 | $0.1500 |
| Feb 28, 2023 | $0.1500 |
| Nov 10, 2022 | $0.1500 |
| Aug 11, 2022 | $0.1500 |
| May 12, 2022 | $0.1400 |
| Feb 28, 2022 | $0.1400 |
| Nov 10, 2021 | $0.1400 |
| Aug 12, 2021 | $0.1400 |
| May 13, 2021 | $0.1300 |
| Feb 26, 2021 | $0.1300 |
| Nov 12, 2020 | $0.1300 |
| Aug 13, 2020 | $0.1300 |